Study guide

3.1 Prescription Requirements, Formats & Electronic Prescribing (EPCS)

Mississippi MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Mississippi MPJE Overview

1.1 Mississippi MPJE Format, Logistics & Official Blueprint 1.2 Study Strategy & Federal vs. Mississippi Legal Hierarchy 1.3 Federal & State Regulatory Authorities & Oversight

2 Chapter 2: Mississippi Pharmacy Governance, Board Structure & Licensure

2.1 Mississippi Board of Pharmacy: Structure, Authority & Operations 2.2 Pharmacist Licensure, Examination, Reciprocity & Continuing Education 2.3 Pharmacy Interns, Externs & Preceptor Requirements 2.4 Pharmacy Technicians: Registration, Scope & Supervision Ratios 2.5 Disciplinary Proceedings, Impairment & Current Monitoring

3 Chapter 3: Pharmacist Practice Standards & Prescribing Authority

3.1 Prescription Requirements, Formats & Electronic Prescribing (EPCS) 3.2 Prescriptive Authority in Mississippi: Physicians, Mid-Level Practitioners & Out-of-State 3.3 Collaborative Drug Therapy Management (CDTM) & Institutional Protocols 3.4 Patient Counseling, Prospective DUR & OBRA '90 Mandates 3.5 HIPAA, Patient Privacy & Confidentiality of Pharmacy Records

4 Chapter 4: Controlled Substances: Scheduling, Ordering & Security

4.1 Federal & Mississippi Controlled Substance Scheduling 4.2 DEA Registration, Mississippi Permitting & Physical Security 4.3 Schedule II Ordering: Single-Sheet DEA Form 222 & Electronic CSOS 4.4 Controlled Substance Inventories: Mississippi Annual Mandate 4.5 Controlled Substance Disposal (DEA Form 41) & Theft/Loss Reporting Protocols

5 Chapter 5: Dispensing Controlled Substances & Prescription Processing

5.1 Schedule II Prescriptions: Issuance, Emergency Oral Dispensing & Sequential Prescriptions 5.2 Partial Filling of Controlled Substances: CARA, Out-of-Stock & Long-Term Care 5.3 Schedule III–V Prescriptions: Refill Limitations, Authorizations & Expirations 5.4 Prescription Transfers: Federal & Mississippi Requirements 5.5 Corresponding Responsibility, Red Flags & Legitimate Medical Purpose

6 Chapter 6: Mississippi Prescription Monitoring Program & Public Health Mandates

6.1 Mississippi Prescription Monitoring Program (MS PMP Gateway): Mandates & 24-Hour Reporting 6.2 Opioid Prescribing Limits, MME Calculations & Acute Pain Restrictions 6.3 Naloxone Standing Order, Overdose Prevention & Harm Reduction Dispensing 6.4 Behind-the-Counter Sales: Pseudoephedrine & Ephedrine Regulations 6.5 Pharmacist Immunization Authority & Protocol Administration in Mississippi

7 Chapter 7: Pharmacy Operations, Permits & Facilities

7.1 Community Pharmacy Permits, Pharmacist-in-Charge (PIC) Duties & Staffing 7.2 Institutional & Hospital Pharmacy Practice Regulations 7.3 Automated Medication Systems, Remote Dispensing & Telepharmacy 7.4 Non-Resident (Mail-Order) Pharmacies, Licensure & Wholesale Distributors 7.5 Drug Supply Chain Security Act (DSCSA), Track-and-Trace & Product Quarantines

8 Chapter 8: Compounding Standards, Safety & Product Selection

8.1 Non-Sterile Compounding (USP <795>): Categories, Beyond-Use Dating & Quality Assurance 8.2 Sterile Compounding (USP <797>): Cleanrooms, ISO Classifications & Aseptic Protocols 8.3 Hazardous Drug Handling (USP <800>): Engineering Controls, PPE & Spill Protocols 8.4 Generic Drug Substitution, FDA Orange Book & Purple Book Biosimilars 8.5 Repackaging, Unit-Dose Beyond-Use Dating & FDA Drug Recall Classifications

9 Chapter 9: Review, Clinical Scenarios & High-Yield Calculations

9.1 High-Yield Scenario Review: Resolving Complex Federal vs. Mississippi Legal Conflicts 9.2 Pharmacy Law Calculations: DEA Verification, Days Supply, Limits & Ratios 9.3 Rapid-Fire Master Review: Key Timelines, Quantities, Retention Periods & Forms 9.4 Exam Day Strategy, Computer-Adaptive Pacing & Distractor Elimination 9.5 High-Frequency MPJE Pitfalls & Distractor Traps

3.1 Prescription Requirements, Formats & Electronic Prescribing (EPCS)

Key Takeaways Explain This Topic AI

A valid prescription must be issued for a legitimate medical purpose by an authorized practitioner acting in the usual course of professional practice.

Controlled-substance prescriptions must contain the patient and practitioner identification, issuance date, drug, strength, dosage form, quantity, directions, and authorized signature required by 21 CFR Part 1306; the practitioner DEA number is required.

Schedule II prescriptions generally require a signed written or compliant electronic prescription, subject to emergency oral dispensing and the federal fax-as-original exceptions.

The SUPPORT Act’s electronic-prescribing rule applies to covered Schedule II–V drugs prescribed under Medicare Part D, subject to federal exceptions; it is not a universal rule invalidating every paper controlled-substance prescription presented in Mississippi.

DEA-compliant EPCS uses identity proofing, logical access controls, two-factor signing, audit controls, and compliant pharmacy applications; electronic transmission does not cure lack of authority or legitimate medical purpose.

Last updated: August 2026

Prescription Validity, Transmission, and EPCS

A prescription is valid only when an authorized practitioner issues it for a legitimate medical purpose while acting in the usual course of professional practice. Format alone never cures a scope or purpose defect. A pharmacist shares responsibility for controlled-substance legitimacy and must resolve material omissions and red flags before dispensing.

Required information

For a controlled substance, 21 CFR § 1306.05 requires the prescription to be dated and signed on the day issued and to contain the patient's full name and address; the practitioner's full name, address, and DEA registration number; and the drug name, strength, dosage form, quantity, directions, and refills if authorized. Schedule II prescriptions have no refills. Schedule III–V prescriptions may authorize no more than five refills within six months.

The regulation does not create a universal “quantity in both numerals and words” rule. Do not reject a prescription solely because the quantity is not spelled out unless another applicable requirement or genuine alteration concern applies. Some missing information may be obtained from reliable records or the practitioner where federal and state law permit annotation; a pharmacist may not use correction as a way to create authority, change the patient, forge a signature, or substitute a different controlled drug.

All Schedule II prescriptions issued together under the federal multiple-prescription rule bear the actual issuance date. Later prescriptions may contain an earliest-fill instruction; they are not postdated. A handwritten controlled-substance prescription requires the practitioner's manual signature. A compliant electronic controlled-substance prescription is signed and transmitted through the EPCS system.

Oral and facsimile prescriptions

Noncontrolled and Schedule III–V prescriptions may generally be communicated orally by an authorized practitioner or agent and reduced to the required record by an authorized pharmacy professional. A new oral prescription is not a technician function.

An oral Schedule II prescription is limited to a bona fide emergency under 21 CFR § 1306.11(d) . The pharmacist limits quantity to the emergency period, immediately reduces the order to writing, and makes a reasonable effort to identify the caller. The practitioner must deliver or postmark the signed follow-up prescription within seven days; if it is not received, the pharmacist notifies DEA as required. Mississippi separately limits an emergency oral Schedule II quantity to no more than a 48-hour supply .

A faxed Schedule II prescription ordinarily allows preparation, with the original required before dispensing. Federal law permits the fax to serve as the original for a Schedule II narcotic compounded for direct parenteral administration to a home-infusion patient, any Schedule II drug for a long-term-care-facility resident, and a Schedule II narcotic for a hospice patient when the prescription is properly noted. Apply the exact exception, not a broad “hospital” or “distance” exception.

Medicaid tamper-resistant paper

Federal Medicaid payment rules require a written outpatient prescription to use tamper-resistant paper with at least one feature from each of three categories: preventing unauthorized copying, preventing erasure or modification, and preventing use of counterfeit forms. Electronic, faxed, and verbal prescriptions are not paper prescriptions. For an emergency fill on noncompliant paper, the pharmacy must obtain a compliant written prescription or verify the prescription by another permitted method within 72 hours for Medicaid payment purposes. This payment rule should not be misstated as making the order void for every patient and payer.

Electronic prescribing

DEA's EPCS regulations allow controlled-substance prescriptions to be created, signed, transmitted, received, and archived electronically through compliant applications. Core safeguards include practitioner identity proofing, controlled assignment of signing permissions, two-factor authentication from distinct categories, audit trails, and application certification or audit. The pharmacy must ensure the electronic record is preserved and readily retrievable for the applicable federal and Mississippi retention periods.

The federal SUPPORT Act electronic-prescribing requirement is directed to covered Schedule II–V controlled substances under Medicare Part D , with statutory and regulatory exceptions. It is not a universal Mississippi rule that automatically invalidates every paper, fax, or otherwise lawful controlled-substance prescription. A pharmacist receiving a non-electronic prescription should apply the dispensing laws and the particular e-prescribing program rule rather than inventing an enforcement duty.

Verification sequence

First verify the practitioner’s identity, license, scope, and DEA authority where needed. Second confirm legitimate medical purpose and patient relationship. Third check content and format. Fourth resolve omissions, alteration concerns, duplicate therapy, PMP information, and other red flags. Document material communications. Never dispense merely because software accepted the claim or an electronic signature appears valid.

Loading diagram... 3.1 Prescription Requirements, Formats & Electronic Prescribing (EPCS) — Current Rule Map